FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Boehringer Ends Phase 3 Study Enrollment for Pulmonary Fibrosis Drug

[ Price : $8.95]

Boehringer Ingelheim completes enrollment of 970 patients in two Phase 3 clinical trials evaluating the safety and efficacy of nin...

FDA Clears Bolton Medical Relay Stent Graft

[ Price : $8.95]

FDA clears a Bolton Medical Relay thoracic aorta stent.

FDA To Begin Policing clinicaltrials.org Certifications

[ Price : $8.95]

HHS delegates authority to FDA to police clinical trial information that is submitted to clinicaltrials.gov as required by the FDA...

Reckitt Benckiser Pulling Suboxone Tablets

[ Price : $8.95]

Reckitt Benckiser withdraws its Suboxone tablets and asks FDA to order companies making products containing buprenorphine to take ...

CDER Official Reviews Outsourcing Responsibilities

[ Price : $8.95]

CDER Office of Manufacturing and Product Quality director Steven Lynn reviews drug sponsor responsibilities when using outsourced ...

CDER Rolling Out New Field Alert Report System

[ Price : $8.95]

A CDER official unveils the agencys plans for a new automated field alert report system for drug manufacturers to use when reporti...

A Year Later, Custom Medical Surgical Kit Recall is Class 1

[ Price : $8.95]

A year after the event, FDA now says a Custom Medical Specialties recall of 14 types of surgical kits was Class 1.

FDA Awards $5 Million Contract for Bioequivalence Studies

[ Price : $8.95]

FDA awards Vince & Associates a five-year contract for research on bioequivalence of branded and generic drugs.

Ranbaxy Misses 9/21 Generic Diovan Launch

[ Price : $8.95]

The Economic Times reports that Ranbaxy missed its intended 9/21 launch of a generic form of Novartis Diovan.

Congress Passes Product Anti-Theft/Counterfeit Act

[ Price : $8.95]

The Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012, which strengthens criminal ...